4//SEC Filing
Greene John 4
Accession 0000950170-25-030181
CIK 0001674416other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:35 PM ET
Size
5.0 KB
Accession
0000950170-25-030181
Insider Transaction Report
Form 4
Greene John
Director
Transactions
- Purchase
Common Shares
2025-02-26$44.85/sh+7,000$313,948→ 7,000 total
Footnotes (2)
- [F1]Open market purchase of shares in accordance with Issuer's trading policies.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.84 to $44.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001610732
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:35 PM ET
- Size
- 5.0 KB